Category : Research & Practice

On Monday 30th September, 2013, UC Davis hosted the 2013 CHAMMP (Center of Health for Advancing Microbiome and Mucosal Protection) Symposium on "Advancing microbiome and mucosal protection in chronic inflammatory disease and development". The event welcomed 8 presentations, with a keynote by Dr Jeffrey Gordon, and ended with a discussion panel.   You can check the program on this page.  …

GMFH Editing Team
GMFH Editing Team

On Monday 30th September, 2013, UC Davis hosted the 2013 CHAMMP (Center of Health for Advancing Microbiome and Mucosal Protection) Symposium on "Advancing microbiome and mucosal protection in chronic inflammatory disease and development". The event welcomed 8 presentations, with a keynote by Dr Jeffrey Gordon, and ended with a discussion panel.   You can check the program on this page.  …

GMFH Editing Team
GMFH Editing Team

The team of Jeffrey Gordon (Ridaura et al. Science 2013) published that the phenotype of obesity (increased adiposity) of an obese twin in a discordant twin pair is transmissible. In other words, they found that mice receiving an obese twin’s fecal microbiota display a greater fat mass than the mice receiving lean twin’s gut microbes. Cohousing is widely used in…

Patrice D. Cani
Professor Patrice D. Cani is researcher from the Belgian Fund for Scientific Research (FRS-FNRS), group leader in the Metabolism and Nutrition research group at the Louvain Drug Research Institute (LDRI) from the Université catholique de Louvain (UCL), Brussels, Belgium, and WELBIO (Walloon Excellence in Lifesciences and BIOtechnology) investigator. He is currently member of several international associations, he is member of the Alumni College from the Royal Belgian Academy of Sciences, and he has been elected in the board of directors of the LDRI (UCL). Patrice D. Cani has a M.Sc. in Nutrition and another M.Sc. in health Sciences, he is registered dietitian and PhD in Biomedical Sciences. His main research interests are the investigation of the role of the gut microbiota in the development of metabolic disorders, such as obesity, type 2 diabetes and low grade inflammation. More specifically, he is investigating the interactions between the gut microbiota, the host and specific biological systems such as the endocannabinoid system and the innate immune system in the context of obesity, type 2 diabetes and metabolic inflammation. Prof Cani is author and co-author of more than 110 scientific research papers published in peer-reviewed international journals, conferences and book chapters.

The team of Jeffrey Gordon (Ridaura et al. Science 2013) published that the phenotype of obesity (increased adiposity) of an obese twin in a discordant twin pair is transmissible. In other words, they found that mice receiving an obese twin’s fecal microbiota display a greater fat mass than the mice receiving lean twin’s gut microbes. Cohousing is widely used in…

Patrice D. Cani
Professor Patrice D. Cani is researcher from the Belgian Fund for Scientific Research (FRS-FNRS), group leader in the Metabolism and Nutrition research group at the Louvain Drug Research Institute (LDRI) from the Université catholique de Louvain (UCL), Brussels, Belgium, and WELBIO (Walloon Excellence in Lifesciences and BIOtechnology) investigator. He is currently member of several international associations, he is member of the Alumni College from the Royal Belgian Academy of Sciences, and he has been elected in the board of directors of the LDRI (UCL). Patrice D. Cani has a M.Sc. in Nutrition and another M.Sc. in health Sciences, he is registered dietitian and PhD in Biomedical Sciences. His main research interests are the investigation of the role of the gut microbiota in the development of metabolic disorders, such as obesity, type 2 diabetes and low grade inflammation. More specifically, he is investigating the interactions between the gut microbiota, the host and specific biological systems such as the endocannabinoid system and the innate immune system in the context of obesity, type 2 diabetes and metabolic inflammation. Prof Cani is author and co-author of more than 110 scientific research papers published in peer-reviewed international journals, conferences and book chapters.

Some individuals seem to be more susceptible to develop obesity or are more resistant to weight loss during dietary restriction. Emerging evidence suggest that few bacterial genera (i.e., Bifidobacterium, Lactobacillus, Faecalibacterium and Akkermansia) are inversely associated with obesity, metabolic inflammation and related metabolic disorders in both human and rodent studies. However so far, a common integrative factor is still being…

Patrice D. Cani
Professor Patrice D. Cani is researcher from the Belgian Fund for Scientific Research (FRS-FNRS), group leader in the Metabolism and Nutrition research group at the Louvain Drug Research Institute (LDRI) from the Université catholique de Louvain (UCL), Brussels, Belgium, and WELBIO (Walloon Excellence in Lifesciences and BIOtechnology) investigator. He is currently member of several international associations, he is member of the Alumni College from the Royal Belgian Academy of Sciences, and he has been elected in the board of directors of the LDRI (UCL). Patrice D. Cani has a M.Sc. in Nutrition and another M.Sc. in health Sciences, he is registered dietitian and PhD in Biomedical Sciences. His main research interests are the investigation of the role of the gut microbiota in the development of metabolic disorders, such as obesity, type 2 diabetes and low grade inflammation. More specifically, he is investigating the interactions between the gut microbiota, the host and specific biological systems such as the endocannabinoid system and the innate immune system in the context of obesity, type 2 diabetes and metabolic inflammation. Prof Cani is author and co-author of more than 110 scientific research papers published in peer-reviewed international journals, conferences and book chapters.

Some individuals seem to be more susceptible to develop obesity or are more resistant to weight loss during dietary restriction. Emerging evidence suggest that few bacterial genera (i.e., Bifidobacterium, Lactobacillus, Faecalibacterium and Akkermansia) are inversely associated with obesity, metabolic inflammation and related metabolic disorders in both human and rodent studies. However so far, a common integrative factor is still being…

Patrice D. Cani
Professor Patrice D. Cani is researcher from the Belgian Fund for Scientific Research (FRS-FNRS), group leader in the Metabolism and Nutrition research group at the Louvain Drug Research Institute (LDRI) from the Université catholique de Louvain (UCL), Brussels, Belgium, and WELBIO (Walloon Excellence in Lifesciences and BIOtechnology) investigator. He is currently member of several international associations, he is member of the Alumni College from the Royal Belgian Academy of Sciences, and he has been elected in the board of directors of the LDRI (UCL). Patrice D. Cani has a M.Sc. in Nutrition and another M.Sc. in health Sciences, he is registered dietitian and PhD in Biomedical Sciences. His main research interests are the investigation of the role of the gut microbiota in the development of metabolic disorders, such as obesity, type 2 diabetes and low grade inflammation. More specifically, he is investigating the interactions between the gut microbiota, the host and specific biological systems such as the endocannabinoid system and the innate immune system in the context of obesity, type 2 diabetes and metabolic inflammation. Prof Cani is author and co-author of more than 110 scientific research papers published in peer-reviewed international journals, conferences and book chapters.

  Although there are numerous studies focusing on structure and function of the gut microbiota, very few is known finally regarding the gut microbial colonization and the host homeostasis.  Some studies already focused on the structural dynamics of the early life gut microbiota, but little is known about factor which allows bacteria to establish in the gut and how the…

GMFH Editing Team
GMFH Editing Team

  Although there are numerous studies focusing on structure and function of the gut microbiota, very few is known finally regarding the gut microbial colonization and the host homeostasis.  Some studies already focused on the structural dynamics of the early life gut microbiota, but little is known about factor which allows bacteria to establish in the gut and how the…

GMFH Editing Team
GMFH Editing Team

As coordinating institute of the MetaHIT consortium and leading expert in gut microbiota research, the French INRA (National Institute for Agricultural Research) has officially inaugurated on July 2nd, 2013 the MetaGenoPolis project. The project receives its €19 million funding from the French Program "Investissements d'Avenir". It is designed as a demonstration initiative, seeking to establish the impact of the gut…

GMFH Editing Team
GMFH Editing Team

As coordinating institute of the MetaHIT consortium and leading expert in gut microbiota research, the French INRA (National Institute for Agricultural Research) has officially inaugurated on July 2nd, 2013 the MetaGenoPolis project. The project receives its €19 million funding from the French Program "Investissements d'Avenir". It is designed as a demonstration initiative, seeking to establish the impact of the gut…

GMFH Editing Team
GMFH Editing Team

There are many questions surrounding the relationship between the functioning of our human body and the presence of the microbes that live in and on us. The current state of knowledge does not allow us to fully understand what impact our microbiota has on our lives. To approach this question, it is important to find out how our gut metagenome…

GMFH Editing Team
GMFH Editing Team

There are many questions surrounding the relationship between the functioning of our human body and the presence of the microbes that live in and on us. The current state of knowledge does not allow us to fully understand what impact our microbiota has on our lives. To approach this question, it is important to find out how our gut metagenome…

GMFH Editing Team
GMFH Editing Team

The Canadian Digestive Health Foundation organized the 4th annual Digestive Health Summit for Healthcare Professionals that took place on Tuesday 5th November, 2013 in Toronto at the Allstream Center. You can check the program and get additional information on their website: http://www.cdhf.ca/en/events/details/id/51   Some videos of the event have been made available : https://www.youtube.com/watch?v=ntD_2QT0bbU https://www.youtube.com/watch?v=ZpswW-LjHu8 https://www.youtube.com/watch?v=rF1HRwy34Qw https://www.youtube.com/watch?v=rFwS9qgT7NY https://www.youtube.com/watch?v=YI6rr6V4mTo https://www.youtube.com/watch?v=yLUvTCLKRmc

GMFH Editing Team
GMFH Editing Team

The Canadian Digestive Health Foundation organized the 4th annual Digestive Health Summit for Healthcare Professionals that took place on Tuesday 5th November, 2013 in Toronto at the Allstream Center. You can check the program and get additional information on their website: http://www.cdhf.ca/en/events/details/id/51   Some videos of the event have been made available : https://www.youtube.com/watch?v=ntD_2QT0bbU https://www.youtube.com/watch?v=ZpswW-LjHu8 https://www.youtube.com/watch?v=rF1HRwy34Qw https://www.youtube.com/watch?v=rFwS9qgT7NY https://www.youtube.com/watch?v=YI6rr6V4mTo https://www.youtube.com/watch?v=yLUvTCLKRmc

GMFH Editing Team
GMFH Editing Team

The intestinal microbiota is known to modulate bioavailability and efficacy of endogenous compounds, nutrients or drugs, with large interindividual variations. The least conserved fraction of our microbiota may hence explain a stratification of the human population in converters and non converters for numerous compounds. As an example, the reduction of cholesterol to coprostanol is only active in a fraction of…

Fernando Aspiroz

The intestinal microbiota is known to modulate bioavailability and efficacy of endogenous compounds, nutrients or drugs, with large interindividual variations. The least conserved fraction of our microbiota may hence explain a stratification of the human population in converters and non converters for numerous compounds. As an example, the reduction of cholesterol to coprostanol is only active in a fraction of…

Fernando Aspiroz

A conference about relation between gut microbiota and colorectal cancer (CRC) was organized by the Canceropole in Paris this June 28th. Experts presented their studies linking different topics : the host microbiota crosstalk, associations between bacteria and cancer and how microbiota could impact antibiotics and anticancer therapies.   Gerard Eberl from Pasteur Institute started the conference insisting about the importance…

GMFH Editing Team
GMFH Editing Team

A conference about relation between gut microbiota and colorectal cancer (CRC) was organized by the Canceropole in Paris this June 28th. Experts presented their studies linking different topics : the host microbiota crosstalk, associations between bacteria and cancer and how microbiota could impact antibiotics and anticancer therapies.   Gerard Eberl from Pasteur Institute started the conference insisting about the importance…

GMFH Editing Team
GMFH Editing Team

In this short video, find out about the key aspects of the Gut Microbiota for Health summit 2013 that took place in Madrid : hot topics, sessions, workshops and networking. Looking forward to welcoming you at the next edition of the event, which will take place in Miami (8-9 March, 2014).   https://www.gutmicrobiotaforhealth.com/videos/videos/best-of-gmfh-2013.mp4

GMFH Editing Team
GMFH Editing Team

In this short video, find out about the key aspects of the Gut Microbiota for Health summit 2013 that took place in Madrid : hot topics, sessions, workshops and networking. Looking forward to welcoming you at the next edition of the event, which will take place in Miami (8-9 March, 2014).   https://www.gutmicrobiotaforhealth.com/videos/videos/best-of-gmfh-2013.mp4

GMFH Editing Team
GMFH Editing Team